Open AccessSelection of Optimum Formulation of RBD-Based Protein Sub-Unit COVID19 Vaccine (Corbevax) Based on Safety and Immunogenicity in an Open-Label, Randomized Phase-1 and 2 Clinical Studies
Author(s) -
Subhash Thuluva,
Vikram Paradkar,
Kishore Thuraga,
SubbaReddy Gunneri,
Vijay Yerroju,
Rammohanreddy Mogulla,
Mahesh Kyasani,
Senthilkumar Manoharan,
Guruprasad R. Medigeshi,
Janmejay Singh,
Heena Shaman,
Chandramani Singh,
Venkateshwar Rao A
Publication year - 2022
Publication title -
ssrn electronic journal
Language(s) - English
Resource type - Journals
ISSN - 1556-5068
DOI - 10.2139/ssrn.4055319
Subject(s) - immunogenicity , selection (genetic algorithm) , virology , phase (matter) , open label , medicine , clinical trial , computer science , immunology , antibody , chemistry , artificial intelligence , organic chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom